A Long-tem Efficacy, Safety, and Tolerability Study of BOTOX in Patients With Chronic Migraine

Trial Profile

A Long-tem Efficacy, Safety, and Tolerability Study of BOTOX in Patients With Chronic Migraine

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Jun 2017

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Acronyms COMPEL
  • Sponsors Allergan
  • Most Recent Events

    • 27 Jun 2017 Results (n=442) of subanalysis assessing efficacy and safety in patients with baseline headache everyday or allodynia, presented at the 3rd Congress of the European Academy of Neurology.
    • 27 Jun 2017 Results of subanalysis evaluating comorbid sleep disturbances and fatigue symptoms presented at the 3rd Congress of the European Academy of Neurology
    • 11 Jun 2017 Results of subanalysis assessing effects of onabotulinumtoxinA prophylaxis on comorbid sleep disturbances and fatigue symptoms, presented at the 59th Annual Scientific Meeting of the American Headache Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top